ZeEBRA (Zebrafish to Enable high-throughput screening of small molecules in Bone disease & Research Analysis) is a R&I FUSION Technology Development Programme (TDP) funded by the Malta Council for Science and Technology (MCST).
The ZeEBRA project will use zebrafish as an improved and robust model for high-throughput screening of small molecules to identify new drug candidates for treating bone disorders, particularly osteoporosis. This will help achieve an active ageing population, promote healthy living, and boost the economy.
The project is a collaborative effort between researchers from the University of Malta (Lead Partner, led by Dr Melissa Formosa from the Department of Applied Biomedical Science and Centre for Molecular Medicine and Biobanking), AquaBioTech Limited (Project Partner) and the Department of Organismal Animal Physiology at Radboud University, Nijmegen, The Netherlands (Project Collaborator).
